TY - JOUR
T1 - Change in dyslipidemia with declining glomerular filtration rate and increasing proteinuria in children with ckd
AU - Saland, Jeffrey M.
AU - Kupferman, Juan C.
AU - Pierce, Christopher B.
AU - Flynn, Joseph T.
AU - Mitsnefes, Mark M.
AU - Warady, Bradley A.
AU - Furth, Susan L.
N1 - Funding Information:
The CKD in Children (CKiD) study is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; U01-DK-66143 (to Dr. Warady), U01-DK-66174 (to Dr. Furth), U01-DK-082194, and U01-DK-66116), with additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute. Dr. Flynn is supported by a grant from NIDDK (U01-DK066143). Dr. Furth and Dr. Warady are supported by grants from the National Institutes of Health. Dr. Mitsnefes, Dr. Pierce, and Dr. Saland are supported by grants from the NIDDK related to the CKiD study.
Publisher Copyright:
© 2019 by the American Society of Nephrology.
PY - 2019/12/6
Y1 - 2019/12/6
N2 - Background and objectives Dyslipidemia, a risk factor for cardiovascular disease, is common in CKD but its change over time and how that change is influenced by concurrent progression of CKD have not been previously described. Design, setting, participants, & measurements In the CKD in Children study we prospectively followed children with progressive CKD and utilized multivariable, linear mixed-effects models to quantify the longitudinal relationship between within-subject changes in lipid measures (HDL cholesterol, non-HDL cholesterol, triglycerides) and within-subject changes in GFR, proteinuria, and body mass index (BMI). Results A total of 508 children (76% nonglomerular CKD, 24% glomerular CKD) had 2–6 lipid measurements each, with a median follow-up time of 4 (interquartile range [IQR], 2.1–6.0) years. Among children with nonglomerular CKD, dyslipidemia was common at baseline (35%) and increased significantly as children aged; 43% of children with glomerular CKD had dyslipidemia at baseline and demonstrated persistent levels as they aged. Longitudinal increases in proteinuria were independently associated with significant concomitant increases in non-HDL cholesterol (nonglomerular: 4.9 [IQR, 3.4–6.4] mg/dl; glomerular: 8.5 [IQR, 6.0–11.1] mg/dl) and triglycerides (nonglomerular: 3% [IQR, 0.8%–6%]; glomerular: 5% [IQR, 0.6%–9%]). Decreases in GFR over follow-up were significantly associated with concomitant decreases of HDL cholesterol in children with nonglomerular CKD (21.2 mg/dl; IQR, 22.1 to 20.4 mg/dl) and increases of non-HDL cholesterol in children with glomerular CKD (3.9 mg/dl; IQR, 1.4–6.5 mg/dl). The effects of increased BMI also affected multiple lipid changes over time. Collectively, glomerular CKD displayed stronger, deleterious associations between within-subject change in non-HDL cholesterol (9 mg/dl versus 1.2 mg/dl; P,0.001) and triglycerides (14% versus 3%; P=0.004), and within-subject change in BMI; similar but quantitatively smaller differences between the two types of CKD were noted for associations of within-subject change in lipids to within-subject change in GFR and proteinuria. Conclusions Dyslipidemia is a common and persistent complication in children with CKD and it worsens in proportion to declining GFR, worsening proteinuria, and increasing BMI.
AB - Background and objectives Dyslipidemia, a risk factor for cardiovascular disease, is common in CKD but its change over time and how that change is influenced by concurrent progression of CKD have not been previously described. Design, setting, participants, & measurements In the CKD in Children study we prospectively followed children with progressive CKD and utilized multivariable, linear mixed-effects models to quantify the longitudinal relationship between within-subject changes in lipid measures (HDL cholesterol, non-HDL cholesterol, triglycerides) and within-subject changes in GFR, proteinuria, and body mass index (BMI). Results A total of 508 children (76% nonglomerular CKD, 24% glomerular CKD) had 2–6 lipid measurements each, with a median follow-up time of 4 (interquartile range [IQR], 2.1–6.0) years. Among children with nonglomerular CKD, dyslipidemia was common at baseline (35%) and increased significantly as children aged; 43% of children with glomerular CKD had dyslipidemia at baseline and demonstrated persistent levels as they aged. Longitudinal increases in proteinuria were independently associated with significant concomitant increases in non-HDL cholesterol (nonglomerular: 4.9 [IQR, 3.4–6.4] mg/dl; glomerular: 8.5 [IQR, 6.0–11.1] mg/dl) and triglycerides (nonglomerular: 3% [IQR, 0.8%–6%]; glomerular: 5% [IQR, 0.6%–9%]). Decreases in GFR over follow-up were significantly associated with concomitant decreases of HDL cholesterol in children with nonglomerular CKD (21.2 mg/dl; IQR, 22.1 to 20.4 mg/dl) and increases of non-HDL cholesterol in children with glomerular CKD (3.9 mg/dl; IQR, 1.4–6.5 mg/dl). The effects of increased BMI also affected multiple lipid changes over time. Collectively, glomerular CKD displayed stronger, deleterious associations between within-subject change in non-HDL cholesterol (9 mg/dl versus 1.2 mg/dl; P,0.001) and triglycerides (14% versus 3%; P=0.004), and within-subject change in BMI; similar but quantitatively smaller differences between the two types of CKD were noted for associations of within-subject change in lipids to within-subject change in GFR and proteinuria. Conclusions Dyslipidemia is a common and persistent complication in children with CKD and it worsens in proportion to declining GFR, worsening proteinuria, and increasing BMI.
UR - http://www.scopus.com/inward/record.url?scp=85076196412&partnerID=8YFLogxK
U2 - 10.2215/CJN.03110319
DO - 10.2215/CJN.03110319
M3 - Article
C2 - 31712386
AN - SCOPUS:85076196412
VL - 14
SP - 1711
EP - 1718
JO - Clinical journal of the American Society of Nephrology : CJASN
JF - Clinical journal of the American Society of Nephrology : CJASN
SN - 1555-9041
IS - 12
ER -